- The Latte
- Hims & Hers stock is too good to ignore after stellar Q3 earnings
Hims & Hers stock is too good to ignore after stellar Q3 earnings
Enjoy these investing infographics?
My good friend Carbon Finance sends out a weekly newsletter with simple, data-driven visuals that cover the most important headlines in investing.
The best part is it’s completely free and only takes 5 minutes to read.
It’s one of our favorite reads each week! Subscribe here now 👉 www.carbonfinance.io/subscribe
The Q3 earnings season has been a mixed bag so far, with some companies thriving due to consumer resilience, while others struggle in a high-interest rate environment.
Telehealth company Hims and Hers ($HIMS) falls into the first category, firing on all cylinders with revenues growing faster than expected, and profitability improving rapidly. HIMS reported Q3 earnings results on Monday, confirming strong growth and profitability momentum, resulting in a sharp increase in the stock price.
Despite this solid fundamental performance, HIMS stock has only risen by 3% this year. It's unclear why it has lagged behind the market despite its stellar top and bottom-line performance. If the robust fundamental performance continues, patient investors could be rewarded as the current valuation is very attractive, presenting a good buying opportunity. Here's why.
Subscribe to Premium Membership to read the rest.
Become a paying subscriber of Premium Membership to get access to this post and other subscriber-only content.
Already a paying subscriber? Sign In